437 related articles for article (PubMed ID: 30232753)
1. ApoE and Neurodegenerative Diseases in Aging.
Yin Y; Wang Z
Adv Exp Med Biol; 2018; 1086():77-92. PubMed ID: 30232753
[TBL] [Abstract][Full Text] [Related]
2. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
[TBL] [Abstract][Full Text] [Related]
3. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders.
Mahley RW
J Mol Med (Berl); 2016 Jul; 94(7):739-46. PubMed ID: 27277824
[TBL] [Abstract][Full Text] [Related]
5. Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes.
Rapp A; Gmeiner B; Hüttinger M
Biochimie; 2006 May; 88(5):473-83. PubMed ID: 16376010
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Marais AD
Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
[TBL] [Abstract][Full Text] [Related]
7. Investigating Effects of Plasma Apolipoprotein E on Ischemic Heart Disease Using Mendelian Randomization Study.
Li MY; Kwok MK; Schooling CM
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34203181
[TBL] [Abstract][Full Text] [Related]
8. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
Baum L; Chen L; Ng HK; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases.
Alagarsamy J; Jaeschke A; Hui DY
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077289
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.
Johnson LA; Olsen RH; Merkens LS; DeBarber A; Steiner RD; Sullivan PM; Maeda N; Raber J
Neurobiol Dis; 2014 Apr; 64():150-62. PubMed ID: 24412220
[TBL] [Abstract][Full Text] [Related]
12. The role of apolipoprotein E in neurodegeneration and cardiovascular disease.
Lopez MF; Krastins B; Ning M
Expert Rev Proteomics; 2014 Jun; 11(3):371-81. PubMed ID: 24754513
[TBL] [Abstract][Full Text] [Related]
13. Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.
Woody SK; Zhou H; Ibrahimi S; Dong Y; Zhao L
J Alzheimers Dis; 2016 Jun; 53(3):1015-31. PubMed ID: 27340853
[TBL] [Abstract][Full Text] [Related]
14. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
Dunk MM; Driscoll I;
J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Mass Spectrometry-Based Apolipoprotein Profiling and Apolipoprotein E Phenotyping in Patients with ASCVD and Mild Cognitive Impairment.
Begcevic Brkovic I; Zöhrer B; Scholz M; Reinicke M; Dittrich J; Kamalsada S; Baber R; Beutner F; Teren A; Engel C; Wirkner K; Thiele H; Löffler M; Riedel-Heller SG; Ceglarek U
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745204
[TBL] [Abstract][Full Text] [Related]
17. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.
Fernández-Calle R; Konings SC; Frontiñán-Rubio J; García-Revilla J; Camprubí-Ferrer L; Svensson M; Martinson I; Boza-Serrano A; Venero JL; Nielsen HM; Gouras GK; Deierborg T
Mol Neurodegener; 2022 Sep; 17(1):62. PubMed ID: 36153580
[TBL] [Abstract][Full Text] [Related]
18. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.
Tsukamoto K; Smith P; Glick JM; Rader DJ
J Clin Invest; 1997 Jul; 100(1):107-14. PubMed ID: 9202062
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E phenotypes and serum lipids in newborns and 3-year-old children: the Cardiovascular Risk in Young Finns Study.
Lehtimäki T; Porkka K; Viikari J; Ehnholm C; Akerblom HK; Nikkari T
Pediatrics; 1994 Oct; 94(4 Pt 1):489-93. PubMed ID: 7936857
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.
Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO
Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
